FDA — authorised 11 August 1961
- Marketing authorisation holder: SHIONOGI INC
- Status: approved
🇺🇸 Cuvposa in United States
FDA authorised Cuvposa on 11 August 1961
Marketing authorisations
FDA — authorised 28 July 2010
- Application: NDA022571
- Marketing authorisation holder: MERZ PHARMS
- Local brand name: CUVPOSA
- Indication: SOLUTION — ORAL
- Status: approved
Cuvposa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Cuvposa approved in United States?
Yes. FDA authorised it on 11 August 1961; FDA authorised it on 28 July 2010.
Who is the marketing authorisation holder for Cuvposa in United States?
SHIONOGI INC holds the US marketing authorisation.